The US chapter USP <800> holds a hazardous-drug compounding room at 0.01 to 0.03 inches of water column negative to adjacent areas, about 2.5 to 7.5 Pa. The band has an upper limit as well as a lower one, so the transmitter, the exhaust control and the tightness of the room all matter more than in a 10 to 15 Pa cascade.
Cleaning validation is often reduced to showing the previous product is gone. EU GMP Annex 15 (2015) also says limits should be established for cleaning agents, microbial and endotoxin risk should be considered when protocols are developed, and the times before and after cleaning should be used to define dirty and clean hold times.
A locked isolator does not stop a fan that windmills in the draught from a neighbouring unit. Isolating an AHU means identifying every energy source, moving air included, shutting down and isolating, one personal lock per worker, releasing stored energy, and trying to start the unit before the door is opened.
Analytical methods are often the last work package in a product transfer. The WHO guideline (TRS 1044, Annex 4) says analytical procedures, including those for cleaning residue samples where applicable, should be implemented at the testing laboratory before process validation samples are tested. That takes qualified laboratory equipment and trained analysts ahead of the first batch.
Every SKU changeover on a packaging line is a chance for a leaflet or label from the previous run to reach the next. EU GMP Chapter 5 says line clearance should follow an appropriate checklist. Five checks cover it: nothing left behind, printed materials matched, counters at zero, bins empty, a second-person check.
ICH Q10 defines the pharmaceutical quality system as the management system to direct and control a pharmaceutical company with regard to quality. It has four elements (monitoring, CAPA, change management, management review) and two enablers (knowledge management, quality risk management). SOPs are how the system is written down.
21 CFR 11.100 sets three general requirements for electronic signatures: each one unique to one individual and never reassigned, identity verified before a signature is assigned, and a certification to FDA that the signatures are the legally binding equivalent of handwritten ones. All three belong in the URS and the site procedure.
An assessor reads what stands behind the registration batches. By the time the first one is made, five things should be true at the receiving site: equipment and rooms qualified, analytical procedures transferred, specifications and suppliers approved, the master batch record issued and operators trained. Each needs a signed document behind it.
An ISO 9001 certificate shows that a supplier's quality management system was audited within a stated scope. It does not show that the equipment or service you bought meets your requirement. Supplier qualification assesses what you buy, against your URS, to a depth set by risk: questionnaire, audit or factory hold points.
A screenshot with no date, tag or user proves little. Evidence attached to an executed protocol should pass five checks: that it shows system, tag, date, time and user, that it is legible and uniquely referenced, that the test step cites it, that the tester signed and dated it, and that the raw data is retained.
ICH M4 makes Modules 2 to 5 of the CTD common in format, but Module 1 is region specific. The ASEAN format, the ACTD, arranges the content in four parts, and the ASEAN stability guideline gives 30 °C/75% RH as the general long-term condition. Fix the target markets early.
Continued process verification is the FDA's Stage 3: assurance during routine production that the process remains in a state of control. EU GMP Annex 15 (2015) calls it ongoing process verification. Continuous process verification, defined in ICH Q8(R2), is an alternative approach to validation. Write the phrase out and cite its source.